Special Drug Use-Results Survey for ZYTIGA Tablets 250 mg (Long-term Use)

Not Applicable

• Conditions: castration-resistant prostate cancer

• Registration Number: JPRN-UMIN000015894
• Lead Sponsor: Janssen Pharmaceutical K.K.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-12-15
• Study Completion: 2018-08-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Male
• Target Recruitment: 420

Inclusion Criteria

Not provided

Exclusion Criteria

NA

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Safety(Adverse Drug Reaction) Effectiveness(PSA Response rate)

Secondary Outcome Measures

Name	Time	Method
Effectiveness(Overall survival)